NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

All BS! You have no idea what you are talking about. MHRA would have rejected their application a while back if Flaskworks/Eden was necessary.

Remember, Kite could only produce dosage for 100 patients during the first year post FDA clearance.

None of the regulatory agencies will place such stringent volume requirements for a personalized immunotherapy product. They understand how expensive it can be to scale and that would damage the company financially even before they start! Thats not how things work. You start small and gradually expand/scale.

Your friends have been messing with you! ;)